Antidepressant use and colorectal cancer risk

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 11, 2009, Pages 1111-1114

  Coogan, Patricia F ^a   Strom, Brian L ^b   Rosenberg, Lynn ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Case control study; Colorectal cancer; Pharmacoepidemiology; Selective serotonin reuptake inhibitors; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; RISK REDUCTION;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CASE-CONTROL STUDIES; CITIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MID-ATLANTIC REGION; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 70549106111     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1808     Document Type: Article

References (14)

1. Xu W, Tamim H, Shapiro S, Stang MR, Collet JP. Use of antidepressants and risk of colorectal cancer: a nested case-control study. Lancet Oncol 2006; 7(4): 301-308.
2. Rosenberg L, Coogan PF, Palmer JR. Case-Control Surveillance. In Pharmacoepidemiology, Strom B (ed). JohnWiley & Sons: Chichester, England, 2005; 185-202.
3. Kroenke CH, Bennett GG, Fuchs C, et al. Depressive symptoms and prospective incidence of colorectal cancer in women. Am J Epidemiol 2005; 162(9): 839-848. (Pubitemid 41541368)
4. PenninxBW, Guralnik JM, Pahor M, et al. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 1998; 90(24): 1888-1893. (Pubitemid 29014222)
5. Coogan PF, Rosenberg L, Strom BL. Statin use and the risk of 10 cancers. Epidemiology 2007; 18(2): 213-219.
6. Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. Am J Epidemiol 2005; 162(2): 165-170. (Pubitemid 41373542)
7. Tutton PJ, Barkla DH. The influence of serotonin on the mitotic rate in the colonic crypt epithelium and in colonic adenocarcinoma in rats. Clin Exp Pharmacol Physiol 1978; 5(1): 91-94.
8. Nocito A, Dahm F, Jochum W, et al. Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts. Cancer Res 2008; 68(13): 5152-5158.
9. Tutton PJ, Barkla DH. Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br J Cancer 1982; 46(2): 260-265.
10. Yue CT, Liu YL. Fluoxetine increases extracellular levels of 3-methoxy- 4-hydroxyphenylglycol in cultured COLO320 DM cells. Cell Biochem Funct 2005; 23(2): 109-114.
11. Arimochi H, Morita K. Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. Eur J Pharmacol 2006; 541(1-2): 17-23. (Pubitemid 43903472)
12. Gil-Ad I, Zolokov A, Lomnitski L, et al. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int J Oncol 2008; 33(2): 277-286.
13. Iishi H, Tatsuta M, Baba M, Taniguchi H. Enhancement by the tricyclic antidepressant, desipramine, of experimental carcinogenesis in rat colon induced by azoxymethane. Carcinogenesis 1993; 14(9): 1837-1840. (Pubitemid 23290897)
14. Arimochi H, Morita K. Desipramine induces apoptotic cell death through nonmitochondrial and mitochondrial pathways in different types of human colon carcinoma cells. Pharmacology 2008; 81(2): 164-172.